entertainment
Previous article:
Duchenne breakthrough therapy leaves behind pioneering families
Next article: 3 questions for the future of Biden's cancer moonshot
Next article: 3 questions for the future of Biden's cancer moonshot
focus
knowledge
-
Histogen: Failed biotech offers rare public look inside
2025-09-28 21:40 -
In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati
2025-09-28 20:33 -
Abbott's new heart device gets FDA advisory panel nod
2025-09-28 20:29 -
VC firm General Catalyst wants to buy a health system
2025-09-28 19:42 -
VC firm General Catalyst wants to buy a health system
2025-09-28 19:37 -
Phenylephrine and the overlooked value of the placebo effect
2025-09-28 19:16